Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergey E Tkachenko

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Expert Opinion on Investigational Drugs|December 13, 2006
VEGF/VEGFR signalling as a target for inhibiting angiogenesisAlex Kiselyov, Konstantin V Balakin, Sergey E Tkachenko
Current Opinion in Chemical Biology|August 4, 2004
Exploring the chemogenomic knowledge space with annotated chemical librariesNikolay P Savchuk, Konstantin V Balakin, Sergey E Tkachenko
Expert Opinion on Therapeutic Patents|August 19, 2010
5-hydroxytryptamine subtype 6 receptor modulators: a patent surveyAlexandre V Ivachtchenko, Yan A Ivanenkov, Sergey E Tkachenko
Mini Reviews in Medicinal Chemistry|June 22, 2006
Recent progress in development of non-ATP competitive small-molecule inhibitors of protein kinasesAlex Kiselyov, Konstantin V Balakin, Sergey E Tkachenko, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 9, 2008
Caspase activity modulators as anticancer agentsIlya Okun, Konstantin V Balakin, Sergey E Tkachenko, et al.
Expert Opinion on Therapeutic Targets|August 2, 2007
Small-molecule modulators of Hh and Wnt signaling pathwaysAlex S Kiselyov, Sergey E Tkachenko, Konstantin V Balakin, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 28, 2007
Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspectiveKonstantin V Balakin, Yan A Ivanenkov, Alex S Kiselyov, et al.
Anti-Cancer Agents in Medicinal Chemistry|March 14, 2007
Recent progress in discovery and development of antimitotic agentsAlex Kiselyov, Konstantin V Balakin, Sergey E Tkachenko, et al.
Journal of Combinatorial Chemistry|September 14, 2004
A parallel solution-phase synthesis of substituted 3,7-diazabicyclo[3.3.1]nonanesAlexander V Ivachtchenko, Sergey E Tkachenko, Yuriy B Sandulenko, et al.
European Journal of Medicinal Chemistry|November 27, 2009
8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonistsAlexandre V Ivachtchenko, Oleg D Mitkin, Sergey E Tkachenko, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Expert Opinion on Investigational Drugs|December 13, 2006
VEGF/VEGFR signalling as a target for inhibiting angiogenesisAlex Kiselyov, Konstantin V Balakin, Sergey E Tkachenko
Current Opinion in Chemical Biology|August 4, 2004
Exploring the chemogenomic knowledge space with annotated chemical librariesNikolay P Savchuk, Konstantin V Balakin, Sergey E Tkachenko
Expert Opinion on Therapeutic Patents|August 19, 2010
5-hydroxytryptamine subtype 6 receptor modulators: a patent surveyAlexandre V Ivachtchenko, Yan A Ivanenkov, Sergey E Tkachenko
Mini Reviews in Medicinal Chemistry|June 22, 2006
Recent progress in development of non-ATP competitive small-molecule inhibitors of protein kinasesAlex Kiselyov, Konstantin V Balakin, Sergey E Tkachenko, et al.
Anti-Cancer Agents in Medicinal Chemistry|April 9, 2008
Caspase activity modulators as anticancer agentsIlya Okun, Konstantin V Balakin, Sergey E Tkachenko, et al.
Expert Opinion on Therapeutic Targets|August 2, 2007
Small-molecule modulators of Hh and Wnt signaling pathwaysAlex S Kiselyov, Sergey E Tkachenko, Konstantin V Balakin, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 28, 2007
Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspectiveKonstantin V Balakin, Yan A Ivanenkov, Alex S Kiselyov, et al.
Anti-Cancer Agents in Medicinal Chemistry|March 14, 2007
Recent progress in discovery and development of antimitotic agentsAlex Kiselyov, Konstantin V Balakin, Sergey E Tkachenko, et al.
Journal of Combinatorial Chemistry|September 14, 2004
A parallel solution-phase synthesis of substituted 3,7-diazabicyclo[3.3.1]nonanesAlexander V Ivachtchenko, Sergey E Tkachenko, Yuriy B Sandulenko, et al.
European Journal of Medicinal Chemistry|November 27, 2009
8-Sulfonyl-substituted tetrahydro-1H-pyrido[4,3-b]indoles as 5-HT6 receptor antagonistsAlexandre V Ivachtchenko, Oleg D Mitkin, Sergey E Tkachenko, et al.
Pageof 4